New flu shot for seniors enters first safety check
NCT ID NCT07421037
Summary
This study aims to check the safety of a new four-strain flu vaccine that includes an ingredient to boost the immune response. It will involve 80 healthy adults aged 65 and older. Researchers will closely monitor participants for any side effects or reactions for up to a year after they receive the shot.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yunxi County Center for Disease Control and Prevention
Shiyan, Hubei, China
Conditions
Explore the condition pages connected to this study.